1. Home
  2. AVDL vs ZUO Comparison

AVDL vs ZUO Comparison

Compare AVDL & ZUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • ZUO
  • Stock Information
  • Founded
  • AVDL 2015
  • ZUO 2006
  • Country
  • AVDL Ireland
  • ZUO United States
  • Employees
  • AVDL N/A
  • ZUO N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • ZUO EDP Services
  • Sector
  • AVDL Health Care
  • ZUO Technology
  • Exchange
  • AVDL Nasdaq
  • ZUO Nasdaq
  • Market Cap
  • AVDL 1.4B
  • ZUO 1.4B
  • IPO Year
  • AVDL 1996
  • ZUO 2018
  • Fundamental
  • Price
  • AVDL $11.66
  • ZUO $9.94
  • Analyst Decision
  • AVDL Strong Buy
  • ZUO Buy
  • Analyst Count
  • AVDL 6
  • ZUO 7
  • Target Price
  • AVDL $24.00
  • ZUO $11.43
  • AVG Volume (30 Days)
  • AVDL 1.7M
  • ZUO 3.2M
  • Earning Date
  • AVDL 11-12-2024
  • ZUO 12-02-2024
  • Dividend Yield
  • AVDL N/A
  • ZUO N/A
  • EPS Growth
  • AVDL N/A
  • ZUO N/A
  • EPS
  • AVDL N/A
  • ZUO N/A
  • Revenue
  • AVDL $138,160,000.00
  • ZUO $445,683,000.00
  • Revenue This Year
  • AVDL $533.23
  • ZUO $7.45
  • Revenue Next Year
  • AVDL $73.08
  • ZUO $7.65
  • P/E Ratio
  • AVDL N/A
  • ZUO N/A
  • Revenue Growth
  • AVDL 1523.50
  • ZUO 7.33
  • 52 Week Low
  • AVDL $10.41
  • ZUO $7.70
  • 52 Week High
  • AVDL $19.09
  • ZUO $10.85
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 40.12
  • ZUO 70.86
  • Support Level
  • AVDL $10.41
  • ZUO $9.85
  • Resistance Level
  • AVDL $16.66
  • ZUO $9.92
  • Average True Range (ATR)
  • AVDL 0.88
  • ZUO 0.04
  • MACD
  • AVDL -0.31
  • ZUO -0.04
  • Stochastic Oscillator
  • AVDL 20.00
  • ZUO 77.27

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

About ZUO Zuora Inc.

Zuora Inc provides cloud-based software on a subscription basis that enables companies in various industries to launch, manage, and transform into a subscription business. The firm offers a Zuora Central platform that acts as an intelligent subscription management hub that automates the subscription order-to-cash process, including quoting, billing, collections, analytics, and revenue recognition. Its products include Zuora Billing, Zuora Revenue, Zuora Payments, Zephr, Zuora Platform, and other software that support and expand upon the core offerings. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: